Email updates

Keep up to date with the latest news and articles from Pediatric Rheumatology and BioMed Central.

Open Access Highly Accessed Case Report

Fatal myocarditis in a child with systemic onset juvenile idiopathic arthritis during treatment with an interleukin 1 receptor antagonist

Andrew S Zeft1*, Shaji C Menon2 and Dylan Miller3

Author Affiliations

1 Children's Hospital, Cleveland Clinic, Pediatric Rheumatology, 9500 Euclid Avenue/A111, Cleveland, OH 44195, USA

2 Division of Pediatric Cardiology, Department of Pediatrics, University of Utah, Salt Lake City, UT 84158, USA

3 Department of Pathology, Intermountain Medical Center, Salt Lake City, UT 84158, USA

For all author emails, please log on.

Pediatric Rheumatology 2012, 10:8 doi:10.1186/1546-0096-10-8

Published: 10 April 2012

Abstract

Background

The pathologic diagnosis of isolated myocarditis without pericardial involvement is uncommonly encountered in systemic onset Juvenile Idiopathic Arthritis (soJIA).

Case

An eleven year-old boy with soJIA died suddenly while being treated with the interleukin 1 (IL-1) receptor inhibitor, anakinra. His autopsy revealed an enlarged heart and microscopic findings were consistent with myocarditis, but not pericarditis. Viral PCR testing performed on his myocardial tissue was negative.

Conclusion

This case illustrates myocarditis as a fatal complication of soJIA, potentially enabled by anakinra.

Keywords:
Arthritis; Myocarditis; Idiopathic; Interleukin; Juvenile